Iris Tumors

Iris tumors are tumors that originate from the cells of the iris, which is the colored part of the eye. The iris is the front part of the eye responsible for determining eye color. Iris tumors can have various types and are considered rare tumors. Iris tumors can be either benign (non-cancerous) or malignant (cancerous). Benign iris tumors are generally less serious and often result in aesthetic issues in the eye.

Iris Tumors

Iris tumors are cancerous tumors that occur in the iris, which is the colored part of the eye responsible for determining eye color. The iris contains pigment cells that determine eye color. Iris tumors are generally considered rare.

There are various types of iris tumors, and here are some common ones:

• Iris Nevus: This is a benign tumor of the iris. It usually remains stable throughout a person's lifetime and often does not require any treatment. However, in some cases, it may grow or potentially transform into a malignant tumor.
• Iris Melanoma: This is a malignant tumor of the iris. Iris melanomas are rare but can be more aggressive than other eye tumors and have the potential to metastasize (spread to distant organs). Early diagnosis and treatment are crucial.

The symptoms of iris tumors often manifest as slowly developing spots or lesions on the iris. Pigmented or non-pigmented lesions may appear on the iris. As the tumor grows, symptoms such as changes in vision, blurred or decreased vision, eye pain or discomfort, and redness or bloodshot eyes may occur. Iris tumors are typically noticeable in the colored part of the eye and lead to changes.

A thorough eye examination by an eye doctor or an oncologist is essential for diagnosing iris tumors. During the examination, fundoscopy and imaging tests may be used to assess the size and characteristics of the tumor. Additionally, a biopsy may be performed to determine whether the tumor is malignant. The treatment of iris tumors can involve surgical intervention, radiotherapy, or proton therapy, depending on the size of the tumor, the extent of its spread, and the patient's overall health. The treatment plan is determined by an eye doctor and an oncologist.